Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | 746.07 | 824.01 | 772.89 | 668.72 |
Depreciation/ Depletion | 62.28 | 105.51 | 115.00 | 109.41 |
Non- Cash Items | -151.60 | -236.77 | -38.27 | -54.88 |
Changesin Working Capital | -399.91 | -337.07 | -182.54 | -295.92 |
Cashfrom Operating Activities | 256.84 | 355.68 | 667.08 | 427.33 |
Capital Expenditures | -18.93 | -64.98 | -15.31 | -17.70 |
Other Investing Cash Flow Items Total | 72.63 | 28.93 | -559.71 | -451.14 |
Cashfrom Investing Activities | 53.70 | -36.05 | -575.02 | -468.84 |
Financing Cash Flow Items | -10.66 | -13.38 | -0.78 | -2.63 |
Total Cash Dividends Paid | -183.43 | -297.21 | -159.74 | -1,519.35 |
Issuance( Retirement)of Debt Net | -41.05 | -35.20 | -19.99 | -49.09 |
Cashfrom Financing Activities | -235.14 | -345.79 | -180.51 | -1,571.07 |
Net Changein Cash | 75.40 | -26.16 | -88.45 | -1,612.58 |
Cash Interest Paid | 10.66 | 13.38 | 0.78 | 2.63 |
Cash Taxes Paid | 153.82 | 302.58 | 225.92 | 204.14 |
Pfizer Dividend Pfizer Bonus Pfizer News Pfizer AGM Pfizer Rights Pfizer Splits Pfizer Board Meetings Pfizer Key Metrics Pfizer Shareholdings Pfizer Profit Loss Pfizer Balance Sheet Pfizer Q1 Results Pfizer Q2 Results Pfizer Q3 Results Pfizer Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks